Chronic Myeloid Leukemia, BCR-ABL1 Positive

general

A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem

60

Centers

90

Active Trials

$9.0B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Chronic Myeloid Leukemia, BCR-ABL1 Positive(60)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.7
2
NCI Comprehensive
Active Research Program
51.7
3
NCI Comprehensive
Active Research Program
51.7
4
NCI Comprehensive
Active Research Program
51.7
5
NCI Comprehensive
Active Research Program
51.7
6
NCI Comprehensive
Active Research Program
51.7
751.7
8
NCI Comprehensive
Active Research Program
51.7
9
NCI Comprehensive
Active Research Program
51.7
10
NCI Comprehensive
Active Research Program
51.7
11
NCI Comprehensive
Active Research Program
51.7
12
NCI Comprehensive
Active Research Program
51.7
13
NCI Comprehensive
Active Research Program
51.7
14
NCI Clinical
Active Research Program
51.7
15
Active Research Program
51.7
16
NCI Comprehensive
Active Research Program
51.7
17
NCI Comprehensive
Active Research Program
51.7
18
Active Research Program
51.7
19
NCI Comprehensive
Active Research Program
51.7
20
Active Research Program
51.7
21
Active Research Program
51.7
22
Active Research Program
51.7
23
Active Research Program
51.7
24
Active Research Program
51.7
25
Active Research Program
51.7
26
Active Research Program
51.7
27
Active Research Program
51.7
28
Active Research Program
51.7
29
Active Research Program
51.7
30
Active Research Program
51.7
31
NCI Comprehensive
32
33
NCI Comprehensive
34
NCI Comprehensive
35
NCI Comprehensive
36
NCI Comprehensive
37
38
NCI Comprehensive
39
40
NCI Comprehensive
41
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
42
43
NCI Comprehensive
44
NCI Clinical
45
NCI Comprehensive
46
NCI Comprehensive
47
Cedars-Sinai CancerLos Angeles, CA
48
NCI Comprehensive
49
50
51
NCI Comprehensive
52
53
54
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
55
56
NCI Comprehensive
57
58
59
60

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →